Genscript Biotech
1548.HK
$2.21
Share price
-0.69%
Change (1 day)
-21.63%
Change (1 year)
Categories
Genscript Biotech (1548.HK) - Cash on Hand
Cash on Hand as of December 2022 : $1.46 B
According to Genscript Biotech
's latest financial reports the company has $1.46 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Genscript Biotech - Cash on Hand chart (from 2015 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2021-12-31 | $1.40 B | 81.96% |
| 2020-12-31 | $0.77 B | 80.8% |
| 2019-12-31 | $0.42 B | -24.46% |
| 2018-12-31 | $0.56 B | 344.77% |
| 2017-12-31 | $0.12 B | -6.98% |
| 2016-12-31 | $0.13 B | 31.57% |
| 2015-12-31 | $0.10 B | 268.28% |
| 2014-12-31 | $28.16 M |